Hello,
Welcome to Insider
- Founders of healthcare startups are under pressure to grow quickly, but doing so can have enormous consequences;
- Scientists are trying to figure out how well Moderna's coronavirus vaccine prevents transmission;
- A $145 million biotech is launching with two drugs for chronic pain and depression.
If you're new to this newsletter, sign up here.
Do you have comments or tips about health insurers or healthcare providers? Email me at slivingston@insider.com or tweet @ShelbyJLiv.
Silicon Valley's demand for rapid startup growth is a recipe for disaster in healthcare
- Founders are under pressure to grow their
startups , an especially hard battle in healthcare. - They're working within a complicated regulatory system that's designed to protect patients.
- The "move fast and break things" ethos doesn't apply when the outcome affects patients.
Do COVID-19 vaccines stop transmission? Top scientists are now recruiting thousands of college students to find out
- A study began on Thursday to see how well
Moderna 's COVID-19 vaccine stops the spread of the virus. - Scientists plan to recruit 12,000 college students across 21 campuses for the clinical trial.
- They hope it will tell us how well vaccines prevent asymptomatic infections and stop transmission.
A top biotech VC and a Juno alum just launched a $145 million startup to take a new approach to chronic pain and depression
- Eliem Therapeutics is launching with two drugs that are already in human tests for chronic pain and depression.
- The biotech was formed from two startups RA Capital has been incubating.
- It is part of a larger push by RA Capital to build biotechs from the bottom up and retain more ownership.
More stories we're reading today:
- Fauci blames a new 'surge' in US COVID-19 cases on variants, travel during spring break, and states prematurely pulling back restrictions (Insider)
- A top official at a Chicago hospital that wrongly administered COVID-19 vaccines to Trump Tower employees has resigned (Insider)
- A billionaire pharma exec close to Andrew Cuomo also got priority access to early COVID-19 tests, report says (Insider)
- With Amazon and Ro on its heels, Uber expands its prescription delivery business (STAT)
- One of Belgium's top virologists is hopeful for this summer. He outlines 3 scenarios for what life might look like as vaccinations ramp up. (Insider)
- Shelby